Biotech

Cardiome Closes US$23 Million Bought Deal Financing

VANCOUVER, BRITISH COLUMBIA: ...

ProMetic Closes the Acquisition of Emergent BioSolutions'' Plasma Collection Center in Winnipeg, Canada

LAVAL, QUEBEC: - Acquisition allows for improved management of plasma supply chain and further vertical integration of manufacturing platform - Plasma collection center to be used as blueprint for future centers - P ...

GLG Life Tech Corporation Announces 2015 Second Quarter Financial Results-Achieves 100% Growth in Q2 Sales

VANCOUVER, BRITISH COLUMBIA: ...

Global Blood Therapeutics Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, CA: ...

iBio to Receive US Patent for Influenza Therapeutic

NEW YORK, NY: ...

Threshold Pharmaceuticals and ATOMIC Initiate First Phase 2 Clinical Trial of Tarloxotinib Bromide* (TH-4000) in Patients With Advanced EGFR-Mutant, T790M-Negative Non-Small Cell Lung Cancer (NSCLC)

SOUTH SAN FRANCISCO, CA: ...

Vivione Biosciences Inc. Operational Update

CALGARY, ALBERTA: ...

ProMetic Successfully Completes First Dosing in Plasminogen Deficient Patients

LAVAL, QUEBEC: - ProMetic's plasminogen confirmed to be safe, well tolerated and without drug-related adverse events - Clinical trial to expand to Europe ...

BioHEP Technologies Ltd. Announces Funds Raised From Loan Agreement

VANCOUVER, BRITISH COLUMBIA: ...

ProMetic to Report its Second Quarter 2015 Financial Results and Hold Conference Call / Webcast

LAVAL, QUEBEC: ...